MissionIR Articles
-
MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Unveils New Hybrid Quantum Solver Designed to Simplify and Accelerate Successful Quantum Technology Adoption
D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, has unveiled a new hybrid quantum solver for addressing nonlinear problems. The new solver, which is capable of handling production-scale use casesup to two million variables with no linearization required, was launched…
-
MissionIRNewsBreaks – Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Issues Reminder for Warrant Holders Regarding Expiration Date
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has released a reminder for holders of outstanding common share purchase warrants issued on July 8, 2022; the company is reminding holders that the warrants are set to expire at 4 p.m. Vancouver time on July 8, 2024. According to the reminder, 41,338,257 warrants…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Officials to Present Results from Alzheimer’s Study at AAIC 2024
Annovis Bio (NYSE: ANVS), a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), will be presenting results from its latest Alzheimer’s study at the Alzheimer’s Association International Conference(R) 2024 (“AAIC”). The conference is slated to run from July 28–Aug. 1, 2024, in Philadelphia as well as online.…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Management Presents During Chardan Transport Platform Tech Series
Freight Technologies (NASDAQ: FRGT), a technology company whose custom-developed Fr8App, an industry-leading freight-matching platform powered by artificial intelligence (“AI”) and machine learning, offers a real-time portal for business-to-business (“B2B”) cross-border shipping and domestic shipping, participated in Chardan’s recent Transport Platform Tech Series event. The event brought together key industry players and highlighted the company’s focus…
-
MissionIRNewsBreaks – Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF) Announces Annual Shareholder Meeting, Outlines Agenda Items for Voting
Reunion Gold (TSX.V: RGD) (OTCQX: RGDFF), a leading gold explorer in the Guiana Shield, has scheduled an annual general and special shareholders meeting. The meeting will be held July 9, 2024, with agenda items that include voting and approving an arrangement with G Mining Ventures. According to the announcement, shareholders will vote to approve a statutory…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Chairman & Chief Owner Featured in Latest Episode of The MiningNewsWire Podcast
McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its McEwen Copper subsidiary. The company’s Chairman and Chief Owner, Rob McEwen, was featured in the latest episode of The MiningNewsWire Podcast as part of IBN’s sustained effort to provide…
-
MissionIRNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Marks Major Milestone in Preparations for NDA Submission, Global Suramin Supply
PaxMedica (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, recently completed its three registration/validation batches of PAX-101, an IV formulation of suramin. “This accomplishment marks a significant step toward submitting a New Drug Application (‘NDA’) to the U.S. Food and Drug Administration (‘FDA’) in the fourth quarter of 2024. This step…
-
MissionIRNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Announces Results of Recent Alzheimer’s Study, Schedules Investor Call
Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug-platform company developing novel therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting the results of its recent phase 2/3 Alzheimer’s study. The study was designed to evaluate Buntanetap, the company’s lead drug candidate. According to the report, key findings indicate that Buntanetap showed…
-
MissionIRNewsBreaks – SenesTech Inc. (NASDAQ: SNES) to Present at Emerging Growth Conference
SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, is scheduled to present at the 72nd Emerging Growth Conference, hosted by leading independent small cap media portal EmergingGrowth.com. Taking place on June 12 – 13, 2024, the event identifies companies in a wide range of growth sectors with strong management teams,…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference
InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, will be featured in this week’s Emerging Growth Conference. The conference is slated for June 12–13, 2024. According to the announcement, InMed Pharmaceuticals CEO Eric A. Adams will be presenting at the two-day event. During his…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Enters Key Northeast Hub with Addition of New England Area Dealer
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, today announced the addition of zero-emissions commercial vehicle dealership, Eco Auto, a Boston, Massachusetts-area dedicated EV dealer. As Mullen’s newest franchise dealer, Eco Auto will cover national fleet opportunities for the company’s full line of commercial electric vehicles with particular focus on the regional New England…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Regains Compliance with Nasdaq Listing Rule 5550(a)(2)
Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company announced today that on June 5, 2024, it received a formal notification from the Listing Qualification Department of the Nasdaq Stock Market that it has regained…
-
MissionIRNewsBreaks – SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) Poised to Help NYC Deal with Rat Menace
SenesTech (NASDAQ: SNES) is a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats. The company has been rapidly growing with its unique solutions, defined by its two main offerings – ContraPest(R) liquid and Evolve(TM) Soft Bait, both of which have demonstrated impressive results in controlling…
-
MissionIRNewsBreaks – Correlate Energy Corp. (CIPI) Leveraging Unique Strategy Amid Transition to Renewables
Correlate (OTCQB: CIPI) is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. CIPI is helping to promote the adoption of renewable energy at a corporate level for mid-tier companies that are often overlooked by large energy companies and consulting firms in the sustainability market. This comes as the transition…
-
MissionIRNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Raises ~$2.7M in Warrant Inducement Offering
SOBR Safe (NASDAQ: SOBR) (“SOBRsafe(TM)”), a provider of next-generation transdermal alcohol detection solutions, recently closed on a warrant inducement offering. The company received gross proceeds of $2,786,174 from the transaction. Aegis Capital Corp. acted as the exclusive placement agent for the offering. To view the Form 8-K filing, visit https://ibn.fm/YMiIC About SOBRsafe(TM) Alcohol misuse is…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the second round of dosing for all nine study participants in the second arm of its human pilot study #2 has been completed. The company anticipates completion of the final arm of the study, GLP-1-H24-2, in July. A three-arm, crossover investigation…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Emerging Growth Conference
Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, has announced that management will present at the Emerging Growth Conference. Clene’s presentation is slated to begin at 2:20 p.m. on June…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Releases Q1 2024 Quarterly Report
Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceuticals and technology, is reporting its first-quarter 2024 revenues. According to the report, the company saw revenues of $408,532 while also strengthening its balance sheet with the completion of an $8.4 million private placement involving existing and new shareholders; shares for the placement were offered at $4 per…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Appoints VP over EMEA, Reports First European Orders
Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, has announced a new position to lead Europe sales efforts. The company has named Alain Van Munster as its new vice president of Europe Middle East and Africa (“EMEA”); Alain has spent more than 25 years in the automotive and fleet industries across Europe, Asia and…
-
MissionIRNewsBreaks – Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’
Nutriband (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. “The company’s AVERSA(TM) can be incorporated into any transdermal patch and includes aversive agents to prevent misuse and accidental exposure to drugs with abuse potential, specifically opioids. AVERSA technology has the potential to improve the safety profile of transdermal drugs…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Globavend Holdings Limited (NASDAQ: GVH) Reports 42.5% Revenue Growth for Fiscal 2025
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for NRX-100 NDA Pathway
- Forward Industries Inc. (NASDAQ: FWDI) Announces Fiscal First Quarter 2026 Financial and Operational Results, and an Update on the SOL Treasury Strategy
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Appoints New Executive Leadership Team
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) to Launch Mudra Experience Studio Developer Platform